TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $454,000 | +4.8% | 31,697 | -0.2% | 0.17% | +5.7% |
| Q4 2021 | $433,000 | -16.7% | 31,767 | 0.0% | 0.16% | -25.8% |
| Q3 2021 | $520,000 | -2.8% | 31,767 | 0.0% | 0.21% | -2.7% |
| Q2 2021 | $535,000 | -12.3% | 31,767 | -4.9% | 0.22% | -19.5% |
| Q1 2021 | $610,000 | -9.2% | 33,408 | -9.5% | 0.27% | -15.8% |
| Q4 2020 | $672,000 | +2.1% | 36,931 | +0.2% | 0.32% | -10.0% |
| Q3 2020 | $658,000 | -0.5% | 36,861 | 0.0% | 0.36% | -6.3% |
| Q2 2020 | $661,000 | +18.0% | 36,861 | 0.0% | 0.38% | -3.5% |
| Q1 2020 | $560,000 | -23.0% | 36,861 | 0.0% | 0.40% | -0.8% |
| Q4 2019 | $727,000 | +14.1% | 36,861 | -0.5% | 0.40% | +6.4% |
| Q3 2019 | $637,000 | -3.2% | 37,029 | -0.4% | 0.38% | -6.0% |
| Q2 2019 | $658,000 | -13.2% | 37,196 | 0.0% | 0.40% | -15.3% |
| Q1 2019 | $758,000 | – | 37,196 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |